Evidence map›Paper›PMID 35899110›Full record

ArticleFrontiers in pharmacology2022

Polysaccharide, the Active Component of

Bo Li, Hui-Ying Wang, Jia-Hui Huang, Wan-Feng Xu, Xiao-Jie Feng, Ze-Ping Xiong, Ying-Jie Dong, Lin-Zi Li, Xinglishang He, Han-Song Wu and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The effects ofIranian journal of basic medical sciences · 2023
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Bo LiZhejiang University of Technology, Hangzhou, China.
Hui-Ying WangZhejiang University of Technology, Hangzhou, China.
Jia-Hui HuangZhejiang University of Technology, Hangzhou, China.
Wan-Feng XuZhejiang University of Technology, Hangzhou, China.
Xiao-Jie FengZhejiang University of Technology, Hangzhou, China.
Ze-Ping XiongZhejiang University of Technology, Hangzhou, China.
Ying-Jie DongZhejiang University of Technology, Hangzhou, China.
Lin-Zi LiZhejiang University of Technology, Hangzhou, China.
Xinglishang HeZhejiang University of Technology, Hangzhou, China.
Han-Song WuZhejiang University of Technology, Hangzhou, China.
Ke ZhangZhejiang University of Technology, Hangzhou, China.
Jie SuZhejiang University of Technology, Hangzhou, China.
Qiao-Xian YuZhejiang Senyu Co., Ltd, Yiwu, China.
Ning-Hua JiangThe Second Affiliated Hospital of Jiaxing University, Jaxing, China.
Gui-Yuan LvZhejiang Chinese Medical University, Hangzhou, China.
Su-Hong ChenZhejiang University of Technology, Hangzhou, China.
Zhejiang University of Technology · CNJiaxing University · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic hypertension (MH) is the most common type of hypertension worldwide because of unhealthy lifestyles, such as excessive alcohol intake and high-sugar/high-fat diets (ACHSFDs), adopted by humans. Poor diets lead to a decrease in the synthesis of short-chain fatty acids (SCFAs), which are produced by intestinal flora and transferred by G protein-coupled receptors (GPCRs), resulting in impaired gastrointestinal function, disrupted metabolic processes, increased blood pressure (BP), and ultimately, MH. It is not clear whether

Indexed as

Dendrobium officinale polysaccharideG protein-coupled receptormetabolic hypertensionshort chain fatty acidsstrengthened enterogastric function

Identifiers

PMID35899110
PMCPMC9310040
OpenAlexW4285010019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.